Rezolute Inc (RZLT)
4.30
+0.29
(+7.23%)
USD |
NASDAQ |
Jun 28, 15:49
Rezolute Cash from Investing (Quarterly): 8.67M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.67M |
| December 31, 2023 | 17.76M |
| September 30, 2023 | 2.606M |
| June 30, 2023 | -6.357M |
| March 31, 2023 | -94.95M |
| December 31, 2022 | -0.083M |
| September 30, 2022 | -0.07M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.006M |
| March 31, 2019 | 0.042M |
| December 31, 2018 | 0.008M |
| September 30, 2018 | 0.187M |
| June 30, 2018 | 1.550M |
| March 31, 2018 | 0.1875M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.0058M |
| June 30, 2017 | -0.0826M |
| March 31, 2017 | -0.0277M |
| December 31, 2016 | -0.0241M |
| September 30, 2016 | -0.061M |
| June 30, 2016 | -0.3174M |
| March 31, 2016 | -0.5169M |
| December 31, 2015 | -0.231M |
| September 30, 2015 | -0.3889M |
| June 30, 2015 | -2.233M |
| March 31, 2015 | -1.059M |
| December 31, 2014 | -0.153M |
| September 30, 2014 | -0.168M |
| June 30, 2014 | -0.82M |
| March 31, 2014 | -0.0034M |
| December 31, 2013 | -0.0034M |
| September 30, 2013 | -0.0035M |
| June 30, 2013 | -0.0033M |
| March 31, 2013 | 0.4475M |
| December 31, 2012 | -0.1949M |
| September 30, 2012 | -0.0642M |
| June 30, 2012 | 0.6448M |
| March 31, 2012 | -0.6468M |
| December 31, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-94.95M
Minimum
Mar 2023
17.76M
Maximum
Dec 2023
-3.812M
Average
--
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Cytokinetics Inc | 32.64M |
| Oragenics Inc | -- |
| GT Biopharma Inc | 5.034M |
| IGM Biosciences Inc | 8.651M |
| 180 Life Sciences Corp | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.24M |
| Cash from Financing (Quarterly) | -0.003M |
| Free Cash Flow | -50.20M |
| Free Cash Flow Per Share (Quarterly) | -0.30 |
| Free Cash Flow Yield | -22.77% |